More Pharma Mergers Will Be Presumed Anticompetitive Under New FTC/DOJ Guidelines

 
• By Brenda Sandburg
  
M&A review
Revised draft merger guidelines make it easier for the government to claim deals are anticompetitive. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Compliance

More from Pink Sheet